Bokus
Patrick Oluwole Abolarin, Abraham Olufemi Asuku, Olugbemi Tope Olaniyan - Parkinson's Disease Biomarkers, Inbunden

Inbunden, Engelska, 2027

Parkinson's Disease Biomarkers

From Bench Discoveries to Bedside

Av Patrick Oluwole Abolarin, Abraham Olufemi Asuku, Olugbemi Tope Olaniyan

Del i serien Neuroscience of Neurodegenerative Disease

1858 kr

Kommande

Beskrivning
Parkinson Disease Biomarkers: Bridging Bench Discoveries to Bedside Solutions represents an in-depth exploration of the fast developing world of biomarker research to revolutionize the diagnosis, prognosis, and therapeutic monitoring of the Parkinson disease (PD). Although tremendous progress has been made in the study of PD pathobiology, the field has never had credible and scalable tools that can describe the heterogeneous and progressive aspects of the disorder. This book showcases prominent views in the fields of molecular neuroscience, clinical neurology, bioengineering and translational medicine, to clarify how cutting edge biomarker innovations, such as molecular signatures and genetic risk factors, imaging modalities, digital phenotyping and peripheral biospecimens, are transforming the future of PD care.The chapters follow the entire process of translational pipeline through a multidisciplinary prism: the identification of mechanistic biomarkers in the laboratory model, its confirmation in patient cohorts, translation of clinical practice, and the development of individual treatment plans. Particular attention is drawn to new platforms like α-synuclein seeding assays, multi-omics profiling, machine-learning-enabled biomarker panels, gut-brain axis markers, and real world digital endpoints.The focus on the innovative developments and ongoing issues such as standardization, regulatory routes, ethical issues, accessibility to care across different countries makes this volume an essential tool in the hands of a researcher, clinician, industry partners, and policy leaders. Finally, the book highlights the future possibilities of biomarker-enabled precision medicine to speed up the process of early detection, enhance disease stratification, inform clinical trials, and provide meaningful and patient-centered solutions at the bedside.Key FeaturesTranslates cutting-edge biomarker discoveries into clinical applications for earlier, more accurate, and personalized diagnosis of Parkinson’s disease.Covers emerging biomarkers and advanced technologies, including molecular, genetic, imaging, fluid-based, and digital biomarkers for disease detection, progression, and monitoring.Bridges laboratory research and patient care, highlighting biomarker validation, therapeutic response, precision medicine, and future directions in Parkinson’s disease management.Ideal for neuroscientists, neurologists, and movement disorder specialists interested in Parkinson’s disease biomarkers and translational research, academicians, researchers, clinicians, and healthcare professionals.
Produktinformation
Utforska kategorier
Mer om författaren

Patrick Oluwole Abolarin, PhD is a neuroscientist and Lecturer in the Department of Physiology, School of Basic Medical Sciences, Babcock University, Nigeria. He earned his PhD in Physiology (Neuroscience) from the University of Ilorin and has developed strong expertise in translational neuroscience, with a research focus on neurodegeneration (particularly Parkinson’s disease), chronic pain, inflammation, and neurotoxicology. His work integrates stereotaxic surgery, sciatic nerve ligation, advanced neurobehavioral paradigms, and neurochemical assays to investigate environmental, nutritional, and non-pharmacological modulators of neurological disorders. Dr. Abolarin has received multiple international awards and competitive grants, including visiting trainee and outreach grants from the International Parkinson and Movement Disorder Society, IBRO poster and prize awards, and travel and symposium grants from international neuroscience organizations. He has actively contributed to neuroscience capacity building through prominent roles in the organization of IBRO-ARC and MDS-sponsored workshops, conferences, and advanced training schools, serving as Secretary and member of several local organizing committees. Beyond research, he is recognized as an engaging educator and effective science communicator, with strong leadership, organizational, and mentoring skills. His academic service includes departmental quality assurance, coordination of student industrial training programs, and active participation in neuroscience outreach initiatives, including Brain Awareness Week activities. His research has been published in reputable peer-reviewed journals. Outside the laboratory, he enjoys playing chess, an interest that reflects his enthusiasm for strategic thinking and problem-solving.Abraham Olufemi Asuku, Ph.D. is a passionate neuroscientist and medical biotechnologist. His area of interest is on mitigation of neurotoxicity, neurodegenerative diseases, and neurodevelopmental disorders by phytochemicals, and also on the applications of nanotechnology for neurodegenerative disease drug delivery. He is a member of the Neuroscience Society of Nigeria, the International Parkinson and Movement Disorder Society, USA, the Physiological Society, United Kingdom. He is an award-winning researcher and has over 90 publications (More than 60 are indexed), including book chapters, research and review articles of good international repute. He has served as a reviewer for many reputable journals. He has also presented seminars at many conferences, both locally and internationally. He was one of the invited guest speakers at the VII International Conference of Universidad Tecnica De Manabi, Ecuador, in 2023. Dr. Asuku was an editor of the book titled Non-pharmacological Intervention for Dementia: A Comprehensive Approach, Bioresources for Managing and Treating Dementia, Apitherapy for Neurodegenerative Diseases (published by CRC Press Taylor and Francis), Evolution and Innovation in Parkinson's Disease Therapies in Under-Resourced Settings, and Implications of Neurotoxic Metals on Neurodegenerative Disease (published by IGI Global Scientific Publishing). Dr. Asuku is currently ranked by Scopus SCI- VAL/Elsevier between 2022 and 2025 among the Top 500 Authors in Neuroscience as number 21 and 93 in Nigeria and Africa, respectively.Olugbemi Tope Olaniyan, is an Associate Professor, Applied Physiology and Biotechnology, Faculty of Basic Medical Sciences, College of Health Sciences, Kwara State University, Malete, Nigeria and a Visiting Professor, Department of Physiology, College of Medicine, Korea University, Seoul, South Korea. He holds a BSc., (University of Ilorin, Nigeria) MSc., PhD. (University of Ibadan, Nigeria) in Physiology and Postdoctoral Fellowship in Biotechnology, Institute de Biotecnologico, Centro de Investigacion Biomedica, University of Granada, Spain. Consistently over the years, he has been ranked among the top 500 scientists in Nigeria with scholarly output from Scopus SCI-VAL/Elsevier between 2020 to 2025, number 7th position in Africa in Medical Sciences and Standford University World’s Top 2% Scientists. He has over 15 years of cognate experience in teaching and research and has trained over 60 graduate students, Co-supervised 5 masters and 2 Ph.D. postgraduate students. In addition, he has published over 90 articles in reputable journals and 250 book chapters in reproductive biology, applied physiology, biotechnology, bioinformatics and biophysics. He is a member of several professional bodies including the Physiological society of Nigeria, Nigerian Bioinformatics and Genomics Networks, Drosophila Africa, AntiVec Network, Genetics Society of America, and West Africa Genetics Society.

Betyg & recensioner

0 recensioner

Inga recensioner tillgängliga.